Improving Patient Education and Reducing Risk

Marcia L. Buck, Pharm.D., FCCP

Pediatr Pharm. 2001;7(7) 

In This Article

Summary

Isotretinoin remains a highly beneficial therapy for the management of severe recalcitrant acne. Its adverse effect profile, however, is substantial. Increasing concern over the known teratogenic effect and the potential association with depression and suicide has prompted renewed efforts to educate patients and reduce the number of affected individuals. Health care professionals need to be aware of new regulations regarding patient education and monitoring, as well as the tools available to assist with the educational process.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....